Glycine transporter type 1 (GLYT1) inhibitor RG1678 : positive results of the proof-of-concept study for the treatment of negative symptoms in schizophrenia

収録刊行物

• Presented at the 49th AnnualMeeting of the American College of Neuropsychopharmacology. Miami Beach, Florida : 5-9 December, 2010

  Presented at the 49th AnnualMeeting of the American College of Neuropsychopharmacology. Miami Beach, Florida : 5-9 December, 2010 2010